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Summary 
CDllc/CD18 is a member of the leukocyte integrin family, heterodimeric adhesion molecules 
that interact with a diverse repertoire of ligands, including bacterial lipopolysaccharide (LPS). 
Their role as signal transducing receptors remains uncertain. We used a heterologous expression 
system to determine if CD11c/CD18  was capable of initiating signal transduction in response 
to LPS-binding, as assessed by the induced translocation of nuclear factor-KB. We have previously 
reported that Chinese hamster ovary (CHO)-K1 fibroblasts, normally unresponsive to LPS, acquire 
serum-dependent macrophage-like responses to LPS when transfected with CD14 (Golenbock, 
D. T., Y. Liu, F. Millham, M. Freeman, and R. Zoeller.  1993.J. Biol. Chem. 268:22055-22059), 
a known LPS receptor. In contrast, CHO cells acquired serum-independent responses to Gram- 
negative bacteria and LPS when transfected with CDllc/CD18 (CHO/CDllc).  In comparison 
to CHO cells transfected with CD14 (CHO/CD14), responses in CHO/CDllc cells were slower, 
required higher endotoxin concentrations for maximal response, and were not inhibited by the 
presence of antibodies to CD14. CD11c/CD18 is, thus, the second phagocyte receptor, in addition 
to CD14, which has been shown to have the capacity to activate cells after binding to LPS. The 
function of this receptor in normal phagocytes may be limited to the recognition of LPS in infected 
tissues, where LPS-CD14 interactions are not favored because of the absence of serum proteins. 
T 
he leukocyte integrins, CDlla-c/CD18, are obligate c~/~8 
heterodimeric molecules consisting of a common 95-kD 
B  subunit  noncovalently attached to a unique o~ subunit: 
180-kD oil (CDlla),  170-kD olM (CD11b), or 150-kD o~X 
(CDllc). These transmembrane glycoproteins are expressed 
on the surface of leukocytes and participate  in numerous 
cell-cell and ceU-substrate interactions (1, 2). Deficiency of 
/3-chain expression, as found in the autosomal recessive dis- 
ease known as leukocyte adhesion deficiency, results in recur- 
rent bacterial infections, presumably due to impaired chemo- 
taxis and bacterial phagocytosis (3).  This leads to impaired 
pus formation and defective wound healing (2). 
A great deal is known about CDlla/CD18  and CD11b/ 
CD18.  CDlla/CD18  (LFA-1),  present on all leukocytes, is 
involved in leukocyte-endothelial cell adhesion and helper and 
cytotoxic T lymphocyte interactions (4). CDllb/CD18 (CR3 
or membrane attack complex [MAC-l] 1) is found primarily 
on mature neutrophils, monocytes, and NK cells. It functions 
as a complement receptor for iC3b and also participates in 
1 Abbreviations used in this  paper: CHO, Chinese  hamster ovary; DHFR, 
dihydrofolate  reductase;  EMSA, electrophoretic  mobility  shift assay;  ICAM, 
intercellular adhesion molecule; LBP, LPS-binding protein; MAC-l, 
membrane  attack complex; NF-KB, nuclear  factor-kappa B; ReLPS, LPS 
from Salmonella minnesota R595; sCD14, soluble CD14. 
monocyte and neutrophil adhesion to endothelial cells (2). 
The third leukocyte integrin, CDllc/CD18 (p150,95 or CR4), 
is found on a variety of cell types including monocytes, mac- 
rophages, granulocytes, and some T and B lymphocytes, and 
is a marker for hairy cell leukemia (3, 5, 6). It is also highly 
expressed on dendritic cells (7). In contrast to CDlla/CD18 
and CDllb/CD18,  the functional role of CD11c/CD18 has 
not been well defined. Like the other leukocyte integrins, 
it is involved in the adhesion of monocytes and granulocytes 
to endothelium (3, 8) and functions as a receptor for fibrino- 
gen (9,  10)  and iC3b opsonized particles (11, 12). 
Although all three leukocyte integrins are capable of binding 
unopsonized bacteria and LPS to monocytes, macrophages, 
and granulocytes (13), it has never been clearly demonstrated 
that this interaction independently triggers a cellular response. 
CD18-deficient PBMC have been shown to respond normally 
to LPS, demonstrating that CD11/CD18 is not essential for 
cellular responses to LPS (14). Recent attention has focused 
on CD14, a 53-kD glycosyl phosphatidylinositol-linked  protein 
present on monocytes, macrophages, and neutrophils, as an 
LPS-signaling molecule (15, 16). Binding of LPS to CD14 
on mononuclear phagocytes results in the production of var- 
ious cytokines, such as IL-1 and TNF-cr  involved in the acute 
inflammatory response (16, 17). However, CD14 has no trans- 
membrane domain, and several  lines of recent evidence strongly 
suggest that the function of CD14 is to bind and amplify 
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brane signal.  The best examples that CD14 does not trans- 
duce a signal come from studies of compounds which com- 
petitively antagonize the effects of endotoxin (18-22), such 
as LPS-induced prostaglandin and cytokine release.  Careful 
ligand-binding studies demonstrated that LPS-receptor an- 
tagonists failed to inhibit the binding of LPS to CD14 at 
concentrations of inhibitor that completely blocked the ability 
of LPS to activate monocytes (22). A second line of evidence 
that CD14 does not transduce membrane signals comes from 
observations that some of the LPS antagonists actually acti- 
vate macrophages from rodent species (18). For example, lipid 
IVa, a tetraacyl lipid A  precursor of lipid A, inhibits LPS- 
induced TNF-ot release from human monocytes, but stimu- 
lates  TNF-ot release  from mouse macrophages.  Studies of 
human and rodent cell lines transfected with murine or human 
CD14 demonstrated that the species-specific agonism or an- 
tagonism of the LPS antagonists does not correlate with the 
species of animal from which the cDNA for CD14 was de- 
rived, but correlates precisely with the species of cell in which 
CD14 is expressed (23), Thus, lipid IVa is an LPS antagonist 
in human fibroblasts transfected with mouse CD14. 
We sought to explore what role, if any, CD18 played in 
LPS-induced cellular signaling.  Because CDllc/CD18 activity 
cannot be easily separated from that of CD14 in a macro- 
phage system, we used a Chinese hamster ovary (CHO)-K1 
fibroblast line engineered to heterologously express the genes 
for CDllc/CD18 (CHO/CDllc) (24). CHO cells are nor- 
mally unresponsive to LPS. However, when transfected with 
the gene for CD14 (CHO/CD14) (25), as little as 1 ng of 
LPS/ml will result in the release of arachidonic acid into the 
culture supernatant (25)  and the translocation of the tran- 
scription factor, nuclear factor-kappa B (NF-KB), into the 
nucleus (26). We chose to examine NF-KB translocation in 
CHO/CDllc because it may be a sentinel event in the acti- 
vation of proinflammatory cytokines (27-29). Furthermore, 
translocation of NF-KB is a convenient method for directly 
assessing LPS-induced signal transduction as it occurs in the 
absence of de novo RNA or protein synthesis (26). Our results 
demonstrate that CD11c/CD18, which is a known integral 
membrane protein, functions as a receptor capable of enabling 
responses to LPS. 
Materials  and Methods 
Reagents.  All solutions were guaranteed sterile and pyrogen- 
free  by the manufacturer, unless otherwise stated. PBS, alpha-MEM, 
and Ham's F-12 were obtained from BioWhittaker, Inc. (Walkers- 
ville, ME)). Ex-Cel1320  was obtained from JRH Biosciences  (Lenexa, 
KS). FCS (LPS gl0 pg/ml) was obtained from Hyclone Laborato- 
ries (Logan, UT). Human serum was derived from clotted whole 
blood from healthy volunteers and heat inactivated at 56  ~ for 45 
rain. Ciprofloxacin was a gift from Miles, Inc. (West Haven, CT). 
Methotrexate,  thymidine,  and t-glutamine  were obtained  from 
Sigma Chemical Co. (St. Louis, MO). LPS from Salmonella min- 
nesota R595 (ReLPS) was a gift from N. Qureshi and K. Takayama 
(University of Wisconsin,  Madison, WI). Lipids were prepared 
as 1 mg/ml dispersed sonicates in pyrogen-free PBS and stored at 
-20~  Before use, the suspensions were thawed and sonicated 
for 3-5 min in a water bath sonicator (Lab. Supplies Co.,  Inc., 
Hicksville, NY). 
Monoclonal Antibodies.  Monoclonal  antibody 60 bca (anti-human 
CD14) was from the American Type  Culture Collection (ATCC) 
(Rockville, MD) and was provided as a serum-free hybridoma su- 
pernatant (Gibco Laboratories, Grand Island, NY) as a gift from 
Dr. Ronald R. Bach (Minneapolis Veterans Administration Hos- 
pital, Minneapolis, MN). TS1/18 mAb (anti-human CD18) (30) 
was also purchased from ATCC and used as ascites; mAbs L29 
(anti-human  CD11c) (31) and IB4 (13) were gifts from Dr. Samuel 
D.  Wright  (The  Rockefeller University,  New  York). FITC- 
conjugated sheep anti-mouse IgG was obtained from Sigma Chem- 
ical Co. 
Bacterial Cultures.  Salmonella minnesota R595 was a gift of Dr. 
C. R. H. Raetz (Duke University, Durham, NC). A single colony 
from a fresh plate was inoculated into Luria broth medium (1% 
tryptone, 0.5% yeast extract, 0.5% NaCI, 0.001 N NaOH) and 
grown to saturation. The number of bacteria was determined by 
serial dilutions and is expressed as CFU per milliliter. Bacteria  were 
washed three times in PBS and stored in 200-/zl aliquots at -80~ 
Although whole bacteria were visibly present after freeze-thaw, 
freezing  resulted in >99% cell death. Nevertheless,  stimulation with 
whole bacteria was carried out in the presence of 10 #g of antibi- 
otic ciprofloxacin/ml to inhibit potential bacterial growth during 
the stimulation  assay. 
Celt Lines.  Cell lines were grown as adherent monolayers in 
tissue culture dishes at 37~  in 5% COJ95% air, and passaged 
twice a week to maintain logarithmic growth. The CHO-K1 cell 
line was obtained from the ATCC. CHO/CD14 was developed  by 
stably cotransfecting the genes for human CD14 and neomycin re- 
sistance (CHO/CD14), while CHO/Neo was transfected with the 
gene for neomycin resistance alone, as described in Golenbock et 
al. (25). DG44, a CHO-K1 dihydrofolate reductase-deficient cell 
line, has been previously described (32) and represents the wild- 
type line for the CD11c/CD18 transfectants. Stable clonal cell lines 
of CHO/CD14, CHO/Neo, and DG44 were maintained in Ham's 
F-12 medium supplemented with 10% FCS and 10/xg of cipro- 
floxacin/ml. 
Bulk CHO/CDllc and CHO intercellular adhesion molecule 
(ICAM) transfectants were gifts from Dr. T. Springer (Center for 
Blood Research, Boston, MA) and are described in detail elsewhere 
(33). Briefly, CHO/CDllc was engineered by cotransfection of 
DG44 with the genes for human CDllc/CD18 and a CHO-di- 
hydrofolate reductase minigene, and selected in purine/pyrimidine- 
free medium. CHO/ICAM is DG44 cotransfected with the genes 
for a domain-deleted form of ICAM-1 and dihydrofolate reductase. 
Bulk CHO/CDllc transfectants were cloned by limiting dilution, 
and a single clonal line which expressed CDllc/CD18 was chosen 
at random to use for the experiments described. CHO/CDllc and 
CHO/ICAM were maintained in nucleotide-free alpha-minimum 
essential medium with 10% dialyzed FCS, 2 mM L-glutamine, 10 
#g ciprofloxacin/ml, 16/xM thymidine, and 0.1 #M methotrexate. 
Cells were grown in the absence of methotrexate for several pas- 
sages before experimentation. 
Flow Cytometry Analysis of CHO Transfectants.  CHO transfec- 
tants growing as monolayers in tissue culture dishes were detached 
from the surface using 1 mM EDTA in PBS and resuspended in 
medium with 10% FCS. 2.5  x  10  s cells were incubated for 30 
min on ice with unconjugated 60 bca mAb, TS1/18 mAb, or L29 
mAb diluted in PBS/2% FCS for a final concentration of 10/~g/ml. 
Cells were washed with 2 ml PBS/2%  FCS and counterstained 
with FITC sheep anti-mouse IgG (Sigma Chemical Co.), diluted 
1:100 in PBS/2% FCS, on ice for 30 min. The cells were washed 
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iodide/ml. Stained cells were analyzed by flow microfluorimetry, 
using a FACScan  |  flow cytometer (Becton Dickinson & Co., Moun- 
tain View,  CA),  as described (25). 
Cell Stimulation.  Unless otherwise noted, cells were stimulated 
under strict serum-free conditions. Before the day of experimenta- 
tion, cells growing as adherent monolayers in tissue culture dishes 
were washed three times with PBS, trypsinized, and resuspended 
in Ex-Cell 320 medium with  10 #g ciprofloxacin/ml (herein re- 
ferred to as Ex-Cell). Cells were washed twice in Ex-Cell to re- 
move FCS, and plated in six-well tissue culture dishes at a density 
of 1  x  106. After overnight incubation at 37~  in 5% CO2/95% 
air,  adherent  monolayers were washed  twice with  Ex-Cell  and 
resuspended in 900 #1 of Ex-Cell or Ex-CeU plus 2% human serum 
and the appropriate stimulant.  For experiments with antibodies, 
cells were preincubated with the mAb diluted 1:30 for 15 min on 
ice before addition of the stimulus.  Culture dishes were then returned 
to a 37~  5% CO2/95%  air environment. At the end of the in- 
cubation period, dishes  were placed on ice to stop cellular activa- 
tion during  the preparation of nuclear extracts. 
Pretmration of  Nuclear Extracts.  The procedure used for the prep- 
aration of nuclear extracts is described in detail in Delude et al. 
(26).  Briefly,  adherent cells  were washed in  tissue culture plates 
with PBS containing 2% FCS, harvested using a rubber policeman, 
and pelleted in a microcentrifuge (Microfuge 11; Beckman Instru- 
ments, Palo Alto,  CA).  Cells were resuspended in 0.4  ml buffer 
(10 mM Tris HC1 pH 7.8,  5 mM MgC12,  10 mM KC1, 0.5 mM 
dithiothreitol, 0.3 mM EGTA, I mM phenylmethyl-sulfonyl fluo- 
ride, 10 mM B-glycerol-phosphate, 0.3 M  sucrose,  and 1.0 #g/ml 
each  of the  following  protease  inhibitors:  aprotinin,  antipain, 
leupeptin, chymostatin, and pepstatin), incubated on ice for 15 min, 
and lysed by adding Nonidet P-40 to 0.5%. Nuclei were collected 
by centrifugation and resuspended in 50 #1 of buffer II (20 mM 
Tris pH 7.8,  5 mM MgCI2, 320 mM KC1,  0.5  mM dithiothre- 
itol, 0.2 mM EGTA, 0.5 mM PMSF, 10 mM/S-glycerol-phosphate, 
25% glycerol, and 1.0 #g/ml protease inhibitors, as above). After 
a 15-rain incubation on ice,  the nuclear extracts were cleared  by 
centrifugation and transferred to a new tube. Protein concentra- 
tion was determined using a protein assay dye reagent concentrate 
(Bio-Rad Laboratories,  Hercules,  CA). 
Electrophoretic Mobility Shift Assay (EMSA).  Two synthetic oli- 
gonucleotides  containing the consensus sequence for NF-IcB-binding 
from the murine Ig Ic light chain gene enhancer (Oligos Etc., Guil- 
ford, CT) were annealed and labeled as described (26). 4 #g of crude 
nuclear extracts and 0.2 ng DNA probe (20,000 cpm) were used 
in a DNA-binding reaction containing 50 #g of polydeoxyinosinic- 
deoxycytidilic acid (the polymer poly[dI-dC].poly[dI-dC]) per ml, 
5% glycerol, and lx  band shift buffer (10 mM Tris HC1 pH 7.8, 
1 mM EDTA, 40 mM KC1,  1 mM dithiothreitol).  The reaction 
was incubated at room temperature for 30 min and size fraction- 
ated by gel electrophoresis on a 4% native polyacrylamide gel (Pro- 
togel brand acrylamide:bisacrylamide  [vol/vo130:0.8];  National Di- 
agnostics Inc., Atlanta,  GA) run at 10 V/cm for 45 min at room 
temperature. Gels were transferred to 3-mm filter paper (Whatman 
Inc., Clifton, NJ), immediately dried under vacuum at 80~  and 
exposed to x-ray film (XAR2; Eastman-Kodak Co., Rochester,  NY) 
overnight  at  -80~  with  an intensifying screen. 
Results and Discussion 
Bulk CHO/CD11c transfectants were incubated with whole 
Salmonella  minnesota R595 under strict serum-free conditions 
over increasing  periods  of time,  and  nuclear  extracts  were 
analyzed  for the  induced  translocation  of NF-gB  (Fig.  1). 
Nuclear localization of NF-gB in CHO/CDllc  was evident 
within  30 min and peaked between  1 and 3  h.  In contrast, 
CHO/CD14 responded within 15 min to the stimulus, peaked 
by 30 rain, and returned to baseline at 3 h. CHO cells trans- 
fected with ICAM-1 (CHO/ICAM)  (24),  a member of the 
Ig super family, were unresponsive to treatment with whole 
bacteria. Because only 30-40%  of the bulk-transfected popu- 
lation  expressed  CDllc/CD18  when  analyzed  by  flow 
microfluorimetry  (data not  shown),  a clonal population  of 
CHO/CDllc  was isolated by limiting dilution (Fig. 2). This 
clonal line responded in a similar manner to stimulation with 
whole Salmonella  minnesota  R595 and was used in all subse- 
quent  experiments. 
We believed that the response of CHO/CDllc  to whole 
Gram-negative bacteria  was mediated  through  the interac- 
tion of LPS with the CD11c/CD18  receptor. To test this hy- 
pothesis,  we incubated  CHO/CD11c  with graded amounts 
of KELPS under serum-free conditions,  and analyzed nuclear 
extracts for NF-gB. A comparison of the dose-response rela- 
tionships shows that CHO/CDllc  are modestly less respon- 
sive to LPS,  compared to CHO/CD14  (Fig.  3).  In CHO/ 
CD14, maximum stimulation was seen between 0.1 and 1/,g 
of LPS/ml, while, in CHO/CDllc,  peak activation occurred 
with 10 ng of LPS/ml. DG44, a DHFK-deficient CHO line 
(32) and the parent cell line to CHO/CDllc,  was unrespon- 
sive to  even  1  #g  LPS/ml.  In  addition,  CHO/ICAM  and 
CHO-K1, transfected with the gene for neomycin resistance 
Figure  1.  Time course of NF-KB translocation 
after exposure to whole Salmonella minnesota  under 
serum-free conditions  in  CHO/CD14,  CHO/ 
ICAM, and CHO/CDllc. CHO/CD14, CHO/ 
CD11c, and CHO/ICAM were prepared as cell 
monolayers under  serum-free conditions, as de- 
scribed in Materials and Methods, and stimulated 
with  106  CFU  of whole  Salmonella minnesota 
R595/ml for time periods ranging from 15 to 180 
min. Nuclear extracts were prepared and localiza- 
tion of NF-gB was determined by EMSA. Nuclear 
NF-gB was evident in the CHO/CD11c line  within 
30 min and maintained throughout  the 3-h time 
course, while, for CHO/CD14, the response  is seen 
by 15 min and returns to baseline at 3 h. CHO/ 
ICAM were unresponsive to this stimulus. 
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Figure  2.  CHO cells transfectcd with CDllc/CD18 bind mAb to CD11c 
and CD18, but not CD14. A clonal isolate of the bulk CHO/CDllc trans- 
fection was generated by limiting dilution and subjected to FACS  |  anal- 
ysis. Shown above is a FACS  |  histogram  of CHO/CD14, CHO/CDllc, 
and CHO/Neo after staining with 60 bca (anti-CD14), TS1/18 (anti-CD18), 
or L29 (anti-CD11c). 
(25),  also failed to respond to LPS (data not shown). While 
the difference in sensitivity to LPS may be due to inherent 
differences between CD14 and CD11c/CD18, it is impossible 
to determine, at this time, if these observations simply reflect 
a lower copy number of receptors in the CHO/CDllc line. 
CD14  is  a  glycosyl phosphatidylinositol-linked protein 
without a transmembrane domain. Efficient binding of LPS 
to CD14 requires the presence of serum proteins, especially 
LPS-binding protein (LBP)  (17, 34-36).  A  soluble form of 
CD14 (sCD14) is also present in serum, and several groups 
have observed that sCD14 is capable of enabling LPS respon- 
siveness in certain cell types which do not express the glycosyl 
phosphatidylinositol-linked form of CD14 (34, 37-41). De- 
spite  the use of strict serum-free conditions, we could not 
eliminate initially the possibility that the signaling we ob- 
served in CHO/CDllc was being mediated through sCD14 
contaminating our ceU culture system. Several lines of evi- 
dence demonstrated that this was not the case. First, unlike 
endothelial calls and several other cell types which do not 
express CD14, neither soluble CD14, nor serum, enabled wild- 
type or mock-transfected CHO cells to respond to LPS (25, 
26).  Furthermore, anti-CD14 mAb inhibited LPS signaling 
in CHO/CD14  stimulated with 1-10 ng of LPS/ml, while 
the response to LPS by CHO/CDllc  was not diminished 
by the presence of this antibody (Fig.  4). Although we have 
not performed extensive experiments with antibodies to the 
leukocyte integrins, experiments with the anti-CD18 mAb 
IB4 did not demonstrate specific inhibition of LPS signaling 
in CHO/CDllc (data not shown). This latter experimental 
result was not surprising, as soluble mAbs to CD18 have not 
been reported to block binding of LPS-coated erythrocytes 
to CD18 in the past (13), nor have any soluble (x-chain anti- 
bodies been reported to block LPS-coated erythrocytes  binding 
to  CDllc,  suggesting  that  the  LPS-binding  domain  on 
CDllc/CD18  is not recognized by existing monoclonals. 
CD14-mediated signaling is markedly enhanced by the ad- 
dition of very small amounts of serum, due to  the effects 
of  LBP (16, 17, 42). CHO/CD14, for example, only minimally 
released arachidonate in response to LPS, even at concentra- 
tions as high as 1,000 ng of LPS/ml (25). Because LPS might 
competitively bind sCD14 present in  serum, we predicted 
that  signaling in our CHO/CDllc  line might actually be 
diminished by the presence of serum. In contrast to CHO/ 
CD14,  NF-KB translocation in CHO/CDllc was significantly 
decreased in  the presence of 2%  human serum, compared 
to serum-free conditions (Fig. 5). Under parallel conditions, 
signaling in CHO/CD14  was enhanced by human serum. 
Thus, the responses observed in CHO/CDllc  to LPS were 
not mediated via sCD14.  CDllc/CD18  represents a trans- 
membrane receptor for LPS that may activate macrophages 
through an entirely novel signaling pathway. 
The leukocyte  integrins are clearly more than adhesion tool- 
Figure  3.  LPS dose-response in 
CHO/CD14,  CHO/CD11c,  and 
DG44 after exposure to LPS under 
serum-free conditions. CHO/CD14, 
CHO/CDllc, and DG44 were pre- 
pared and plated under  serum-free 
conditions  and  stimulated  with 
varying concentrations of ReLPS for 
I h. Nuclear extracts were prepared 
and analyzed by the EMSA. Both 
CHO/CD14 and CHO/CD11c re- 
sponded  to KELPS, as reflected by 
the inducible  translocation  of NF- 
KB, in contrast to wild-type DG44. 
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on NF-gB translocation  in CHO/CD14 
and CHO/CDllc exposed to LPS, un- 
der serum-free  conditions. CHO/CD14 
and CHO/CD11c were prepared and 
plated  under  serum-free conditions. 
Cells were preincubated with  either 
PBS, or 60 bca (anti-CD14 mAb) di- 
luted 1:30 for 15 min on ice. Stimula- 
tion was then carried out with varying 
concentrations of KELPS for 1 h. Nu- 
clear extracts were prepared and ana- 
lyzed by the  EMSA. Unlike  CHO/ 
CD14, stimulation  in CHO/CDllc was 
not inhibited by the presence of anti- 
CD14 mAb (.4). CHO/Neo were un- 
responsive to KELPS  in both the pres- 
ence and absence of 60 bca (data not 
shown). Scanning densitometry of the 
autoradiograph was performed and il- 
lustrates graphically the  ratio  of nu- 
clear NF-rB in stimulated/unstimuhted 
cells (B). 
ecules with a purely mechanical function. Several recent reports 
demonstrate their role in cell signaling. For example, spreading 
of macrophages, a CD11/CD18-dependent  process, has been 
shown to induce the synthesis of IL-la and IL-1B (43). Cell- 
associated IL-1B has  also been  observed in  monocytes  as  a 
result  of cross-linking  CDlla,  CDllb,  or  CD18  antigens 
with  antibody (44). Similarly, binding of neutrophils to im- 
Figure  5.  Effect  of human serum on NF-rB translocation in CHO/ 
CD11c exposed  to LPS. CHO/CD14, CHO/CD11c, and CHO/Neo were 
plated in either Ex-CeU, or Ex-Cdl with 2% human serum heat-inactivated 
to 56~  for 45 min. Stimulation was carried out with varying concentra- 
tions of KELPS for 1 h. Above is the EMSA of nuclear extracts prepared 
from CHO/CDllc, demonstrating that translocation of NF-rB was in- 
hibited by the presence  of serum. Simultaneous  stimulation of CHO/CD14 
was enhanced by the presence of serum (data not shown). Scanning den- 
sitometry of the autoradiographs showed that the ratio of nuclear NF-rB 
in stimulated/unstimulated CHO/CD14 cells increased  by 2.8-fold in the 
presence of serum. In contrast, densitometry of the autoradiograph shown 
above revealed that serum reduced the effects  of LPS by 1.4- and 2.6-fold 
(1 and 10 ng of LPS/ml, respectively). 
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mobilized anti-CD18,  anti-CDlla,  or anti-CDllc antibodies 
triggered  the  release  of hydrogen  peroxide  (45),  and  con- 
canavalin A  binding  to  CDllc  activated an oxidative burst 
in  phagocytes  (46).  In  view  of these  data,  it  seems  likely 
that the leukocyte integrins are capable of directly transducing 
signals  after binding  to  their  respective ligands,  including 
bacterial  LPS. 
The  discovery that  CD14  could  function  as  a  signaling 
receptor for LPS-LBP complexes was a significant contribu- 
tion to the understanding  of macrophage and neutrophil ac- 
tivation by LPS  (16).  Since  then,  several investigators  have 
found evidence to suggest  that alternative pathways coexist 
(22, 47, 48), but none of these CD14-independent  pathways 
have been identified.  CDllc/CD18  is, thus, the first alterna- 
tive  LPS-signaling  pathway  to  be defined. 
CD14 appears to be the predominant LPS receptor on pe- 
ripheral monocytes. In blood stream infections, where serum 
and LBP are ample,  CD14 is likely the major LPS-receptor 
involved in  the acute cytokine response  to invading Gram- 
negative bacteria. This would account for the ability of CD18- 
deficient monocytes, which  express CD14,  to respond nor- 
mally to LPS (14). Although CD14-deficient knock-out mice 
were found to be extremely hyporesponsive to injected LPS 
(49),  we propose  that  macrophages  may encounter  Gram- 
negative bacteria under a variety of situations which poorly 
resemble the interactions of injected LPS with blood mono- 
cytes. Tissue infections,  especially infections at mucosal sur- faces and in abscess cavities, may occur in the absence of serum- 
derived proteins which catalyze LPS interactions with CD14. 
In addition, tissue macrophages may differ from blood mono- 
cytes in the relative expression  of CD14, in comparison to 
other LPS receptors. The importance of LPS is generally con- 
sidered  in the narrow context of sepsis and cytokine over- 
production. Yet other effects of LPS, including the influence 
of LPS as a costimulatory molecule during the development 
of specific immunity to Gram-negative bacteria,  may be just 
as profound. Further delineation of the mechanisms involved 
in activation of leukocytes by invading pathogenic Gram- 
negative bacteria will not only enhance our understanding 
of the host's response  to infection, but may open up new 
avenues for therapeutic intervention. 
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